APA (7th ed.) Citation

Kang, L., Kwon, E., Lee, K. M., Cho, C., Lee, J., Ryu, Y. B., . . . Lee, S. (2018). 3'-Sialyllactose as an inhibitor of p65 phosphorylation ameliorates the progression of experimental rheumatoid arthritis. British Journal of Pharmacology, 175(23), 4295. https://doi.org/10.1111/bph.14486

Chicago Style (17th ed.) Citation

Kang, Li‐Jung, et al. "3'-Sialyllactose as an Inhibitor of P65 Phosphorylation Ameliorates the Progression of Experimental Rheumatoid Arthritis." British Journal of Pharmacology 175, no. 23 (2018): 4295. https://doi.org/10.1111/bph.14486.

MLA (9th ed.) Citation

Kang, Li‐Jung, et al. "3'-Sialyllactose as an Inhibitor of P65 Phosphorylation Ameliorates the Progression of Experimental Rheumatoid Arthritis." British Journal of Pharmacology, vol. 175, no. 23, 2018, p. 4295, https://doi.org/10.1111/bph.14486.